VIRAMUNE Side Effects

7020847-5 | Abortion Spontaneous
on Sep 22, 2010 Female patient from , 37 years of age, was diagnosed with antiviral treatment and was treated with Viramune (View Usage). Patient experienced the following unwanted or unexpected effects: abortion spontaneous. Viramune dosage: 400 Mg. During the same period patient was treated with EPZICOM (View Epzicom Review and Epzicom Label ).

7012867-1 | Abortion Spontaneous
Patient was taking Viramune (View Usage). Patient had the following side effects: abortion spontaneous on Sep 14, 2010 from Additional patient health information: Female patient , 42 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Viramune dosage: 400 Mg. During the same period patient was treated with STAVUDINE (View Stavudine Review and Stavudine Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ).

6992711-9 | Abortion Spontaneous
Adverse event was reported on Sep 09, 2010 by a Female patient taking Viramune (View Usage) (Dosage: 400 Mg) was diagnosed with antiviral treatment and. Location: , 37 years of age, After Viramune was administered, patient had the following side effects: abortion spontaneous. During the same period patient was treated with EPZICOM (View Epzicom Review and Epzicom Label ).

6957651-X | Pyrexia, Rash
on Aug 23, 2010 Male patient from , 39 years of age, was treated with Viramune (View Usage). Patient experienced the following unwanted or unexpected effects: pyrexia, rash (What is rash?). Viramune dosage: . Patient was hospitalized.


6955518-4 | Feeling Abnormal, Nonspecific Reaction
on Aug 16, 2010 Male patient from , 61 years of age, was treated with Viramune (View Usage). Patient had the following side effects: feeling abnormal, nonspecific reaction. Viramune dosage: .

6942479-7 | Abortion Induced
Patient was taking Viramune (View Usage). After Viramune was administered, patient had the following side effects: abortion induced on Aug 20, 2010 from Additional patient health information: Female patient , 32 years of age, was diagnosed with antiviral treatment and. Viramune dosage: 400 Mg. During the same period patient was treated with EPZICOM (View Epzicom Review and Epzicom Label ).

6931986-9 | Placental Disorder
Adverse event was reported on Aug 10, 2010 by a Female patient taking Viramune (View Usage) (Dosage: 400 Mg) was diagnosed with hiv infection (What is hiv infection?) and. Location: , 28 years of age, Patient experienced the following unwanted or unexpected effects: placental disorder. During the same period patient was treated with EPZICOM (View Epzicom Review and Epzicom Label ).

6930939-4 | Abortion Induced
on Aug 09, 2010 Female patient from , 32 years of age, was diagnosed with antiviral treatment and was treated with Viramune (View Usage). Patient had the following side effects: abortion induced. Viramune dosage: 400 Mg. During the same period patient was treated with EPZICOM (View Epzicom Review and Epzicom Label ).

6927778-7 | Neutropenia
on Aug 13, 2010 Male patient from , weighting 4.19 lb, was diagnosed with vertical infection transmission and was treated with Viramune (View Usage). After Viramune was administered, patient had the following side effects: neutropenia. Viramune dosage: 8 Mg. During the same period patient was treated with ZIDOVUDINE (16 Mg) (View Zidovudine Review and Zidovudine Label ).

6922180-6 | Abortion Spontaneous
Patient was taking Viramune (View Usage). Patient experienced the following unwanted or unexpected effects: abortion spontaneous on Aug 06, 2010 from Additional patient health information: Female patient , 29 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Viramune dosage: 400 Mg. During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ), COMBIVIR (View Combivir Review and Combivir Label ).

6922171-5 | Arrhythmia
Adverse event was reported on Aug 05, 2010 by a Female patient taking Viramune (View Usage) (Dosage: ) . Location: , weighting 7.28 lb, Patient had the following side effects: arrhythmia (What is arrhythmia?). During the same period patient was treated with COMBIVIR (View Combivir Review and Combivir Label ).

6922075-8 | Premature Closure Of Cranial Sutures
on Aug 05, 2010 Male patient from , weighting 5.95 lb, was treated with Viramune (View Usage). After Viramune was administered, patient had the following side effects: premature closure of cranial sutures. Viramune dosage: . During the same period patient was treated with COMBIVIR (View Combivir Review and Combivir Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), KALETRA (View Kaletra Review and Kaletra Label ), FERROUS SULFATE (View Ferrous Sulfate Review and Ferrous Sulfate Label ), KETOCONOZOLE (View Ketoconozole Review and Ketoconozole Label ).

6922074-6 | Feeling Abnormal, Leukopenia, Lymphadenopathy, Pyrexia, Tonsillitis
on Aug 09, 2010 Female patient from , weighting 194.0 lb, was diagnosed with hiv infection (What is hiv infection?), tonsillitis and was treated with Viramune (View Usage). Patient experienced the following unwanted or unexpected effects: feeling abnormal, leukopenia, lymphadenopathy, pyrexia, tonsillitis. Viramune dosage: 400 Mg. During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ), AMOXICILLIN (2 G) (View Amoxicillin Review and Amoxicillin Label ). Patient was hospitalized.

6921958-2 | Aplasia Cutis Congenita, Umbilical Hernia
Patient was taking Viramune (View Usage). Patient had the following side effects: aplasia cutis congenita, umbilical hernia on Aug 05, 2010 from Additional patient health information: Male patient , weighting 6.39 lb, . Viramune dosage: . During the same period patient was treated with METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), VIDEX (View Videx Review and Videx Label ), COMBIVIR (View Combivir Review and Combivir Label ), EPIVIR (View Epivir Review and Epivir Label ), KALETRA (View Kaletra Review and Kaletra Label ).

6921896-5 | Aplasia Cutis Congenita
Adverse event was reported on Aug 05, 2010 by a Male patient taking Viramune (View Usage) (Dosage: ) . Location: , weighting 6.83 lb, After Viramune was administered, patient had the following side effects: aplasia cutis congenita. During the same period patient was treated with DIDANOSINE (View Didanosine Review and Didanosine Label ), COMBIVIR (View Combivir Review and Combivir Label ), CEFALEXIN (View Cefalexin Review and Cefalexin Label ), FERROUS SULFATE (View Ferrous Sulfate Review and Ferrous Sulfate Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), NITROFURANTOIN (View Nitrofurantoin Review and Nitrofurantoin Label ).

6921635-8 | Atrial Septal Defect, Small For Dates Baby
on Aug 03, 2010 Male patient from , weighting 3.75 lb, was treated with Viramune (View Usage). Patient experienced the following unwanted or unexpected effects: atrial septal defect, small for dates baby. Viramune dosage: . During the same period patient was treated with ALUMINUM HYDROXIDE GEL (View Aluminum Hydroxide Gel Review and Aluminum Hydroxide Gel Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), CEFALEXIN (View Cefalexin Review and Cefalexin Label ), FERROUS SULFATE (View Ferrous Sulfate Review and Ferrous Sulfate Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), HYOSCINE (View Hyoscine Review and Hyoscine Label ), METAMIZOLE SODIUM (View Metamizole Sodium Review and Metamizole Sodium Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ).

6920888-X | Microphthalmos, Umbilical Hernia
on Aug 03, 2010 Male patient from , weighting 6.39 lb, was treated with Viramune (View Usage). Patient had the following side effects: microphthalmos, umbilical hernia. Viramune dosage: . During the same period patient was treated with DIDANOSINE (View Didanosine Review and Didanosine Label ), NELFINAVIR MESYLATE (View Nelfinavir Mesylate Review and Nelfinavir Mesylate Label ), CEFALEXIN (View Cefalexin Review and Cefalexin Label ).

6917592-0 | Ventricular Septal Defect
Patient was taking Viramune (View Usage). After Viramune was administered, patient had the following side effects: ventricular septal defect on Aug 03, 2010 from Additional patient health information: Male patient , weighting 6.39 lb, . Viramune dosage: . During the same period patient was treated with COMBIVIR (View Combivir Review and Combivir Label ), BACTRIM (View Bactrim Review and Bactrim Label ), FERROUS SULFATE (View Ferrous Sulfate Review and Ferrous Sulfate Label ).

6911732-5 | Stillbirth
Adverse event was reported on Jul 28, 2010 by a Female patient taking Viramune (View Usage) (Dosage: ) was diagnosed with antiviral treatment and. Location: , 23 years of age, Patient experienced the following unwanted or unexpected effects: stillbirth. During the same period patient was treated with VIRACEPT (View Viracept Review and Viracept Label ), COMBIVIR (View Combivir Review and Combivir Label ), DIPHENHYDRAMINE (View Diphenhydramine Review and Diphenhydramine Label ).

6911183-3 | Stillbirth
on Jul 28, 2010 Female patient from , 33 years of age, was treated with Viramune (View Usage). Patient had the following side effects: stillbirth. Viramune dosage: . During the same period patient was treated with COMBIVIR (View Combivir Review and Combivir Label ), BACTRIM (View Bactrim Review and Bactrim Label ), CEFTRIAXONE (View Ceftriaxone Review and Ceftriaxone Label ), ETHAMBUTOL HYDROCHLORIDE (View Ethambutol Hydrochloride Review and Ethambutol Hydrochloride Label ), FERROUS SULFATE (View Ferrous Sulfate Review and Ferrous Sulfate Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ).

6911069-4 | Stillbirth
on Jul 28, 2010 Female patient from , 31 years of age, was diagnosed with antiviral treatment and was treated with Viramune (View Usage). After Viramune was administered, patient had the following side effects: stillbirth. Viramune dosage: . During the same period patient was treated with COMBIVIR (View Combivir Review and Combivir Label ), EPIVIR (View Epivir Review and Epivir Label ), VIRACEPT (View Viracept Review and Viracept Label ), COCAINE (View Cocaine Review and Cocaine Label ), FERROUS SULFATE (View Ferrous Sulfate Review and Ferrous Sulfate Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), MARIJUANA (View Marijuana Review and Marijuana Label ).

6911068-2 | Stillbirth
Patient was taking Viramune (View Usage). Patient experienced the following unwanted or unexpected effects: stillbirth on Jul 28, 2010 from Additional patient health information: Female patient , 30 years of age, was diagnosed with hiv infection (What is hiv infection?), antiviral treatment and. Viramune dosage: . During the same period patient was treated with COMBIVIR (View Combivir Review and Combivir Label ), AMPICILLIN SODIUM (View Ampicillin Sodium Review and Ampicillin Sodium Label ), AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ), BETAMETHASONE (View Betamethasone Review and Betamethasone Label ), FERROUS SULFATE (View Ferrous Sulfate Review and Ferrous Sulfate Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), HEXOPRENALINE SULFATE (View Hexoprenaline Sulfate Review and Hexoprenaline Sulfate Label ), IBUPROFEN TABLETS (View Ibuprofen Tablets Review and Ibuprofen Tablets Label ).

6910856-6 | Stillbirth
Adverse event was reported on Jul 28, 2010 by a Female patient taking Viramune (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: , 38 years of age, Patient had the following side effects: stillbirth. During the same period patient was treated with COMBIVIR (View Combivir Review and Combivir Label ), DIPHENHYDRAMINE (View Diphenhydramine Review and Diphenhydramine Label ).

6910816-5 | Stillbirth
on Jul 28, 2010 Female patient from , 23 years of age, was diagnosed with antiviral treatment and was treated with Viramune (View Usage). After Viramune was administered, patient had the following side effects: stillbirth. Viramune dosage: . During the same period patient was treated with COMBIVIR (View Combivir Review and Combivir Label ), AMOXICILLIN TRIHYDRATE (View Amoxicillin Trihydrate Review and Amoxicillin Trihydrate Label ), AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ), BACTRIM (View Bactrim Review and Bactrim Label ), CEFALEXIN (View Cefalexin Review and Cefalexin Label ), IRON PREPARATIONS (View Iron Preparations Review and Iron Preparations Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ).

6910760-3 | Stillbirth
on Jul 28, 2010 Female patient from , 35 years of age, was diagnosed with antiviral treatment and was treated with Viramune (View Usage). Patient experienced the following unwanted or unexpected effects: stillbirth. Viramune dosage: . During the same period patient was treated with VIRACEPT (View Viracept Review and Viracept Label ), COMBIVIR (View Combivir Review and Combivir Label ), NYSTATIN (View Nystatin Review and Nystatin Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), AMINOPHYLLINE (View Aminophylline Review and Aminophylline Label ), AMOXICILLIN TRIHYDRATE (View Amoxicillin Trihydrate Review and Amoxicillin Trihydrate Label ), BACTRIM (View Bactrim Review and Bactrim Label ).

6910759-7 | Stillbirth
Patient was taking Viramune (View Usage). Patient had the following side effects: stillbirth on Jul 28, 2010 from Additional patient health information: Female patient , 34 years of age, . Viramune dosage: . During the same period patient was treated with COMBIVIR (View Combivir Review and Combivir Label ), TRIMETHOPRIM + SULFAMETHOXAZOLE (View Trimethoprim + Sulfamethoxazole Review and Trimethoprim + Sulfamethoxazole Label ), FERROUS SULFATE (View Ferrous Sulfate Review and Ferrous Sulfate Label ).

6910646-4 | Stillbirth
Adverse event was reported on Jul 28, 2010 by a Female patient taking Viramune (View Usage) (Dosage: ) was diagnosed with antiviral treatment and. Location: , 35 years of age, After Viramune was administered, patient had the following side effects: stillbirth. During the same period patient was treated with VIRACEPT (View Viracept Review and Viracept Label ), COMBIVIR (View Combivir Review and Combivir Label ), AMPICILLIN SODIUM (View Ampicillin Sodium Review and Ampicillin Sodium Label ), FLUNARIZINE (View Flunarizine Review and Flunarizine Label ), MEBENDAZOLE (View Mebendazole Review and Mebendazole Label ), METHYLDOPA (View Methyldopa Review and Methyldopa Label ), OXYTOCIN (View Oxytocin Review and Oxytocin Label ).

6909584-2 | Hip Dysplasia
on Jul 27, 2010 Female patient from , weighting 4.85 lb, was treated with Viramune (View Usage). Patient experienced the following unwanted or unexpected effects: hip dysplasia. Viramune dosage: . During the same period patient was treated with NELFINAVIR MESYLATE (View Nelfinavir Mesylate Review and Nelfinavir Mesylate Label ), COMBIVIR (View Combivir Review and Combivir Label ), FERROUS SULFATE (View Ferrous Sulfate Review and Ferrous Sulfate Label ), FEXOFENADINE (View Fexofenadine Review and Fexofenadine Label ), HYOSCINE (View Hyoscine Review and Hyoscine Label ), KETOPROFEN (View Ketoprofen Review and Ketoprofen Label ), METAMIZOLE (View Metamizole Review and Metamizole Label ).

6909540-4 | Knee Deformity
on Jul 27, 2010 Female patient from , weighting 7.05 lb, was treated with Viramune (View Usage). Patient had the following side effects: knee deformity. Viramune dosage: . During the same period patient was treated with FERROUS FUMARATE (View Ferrous Fumarate Review and Ferrous Fumarate Label ), TOBACCO (View Tobacco Review and Tobacco Label ), VIDEX (View Videx Review and Videx Label ), COMBIVIR (View Combivir Review and Combivir Label ), RETROVIR (View Retrovir Review and Retrovir Label ).

6909197-2 | Premature Closure Of Cranial Sutures
Patient was taking Viramune (View Usage). After Viramune was administered, patient had the following side effects: premature closure of cranial sutures on Jul 27, 2010 from Additional patient health information: Male patient , weighting 5.95 lb, . Viramune dosage: . During the same period patient was treated with COMBIVIR (View Combivir Review and Combivir Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), KALETRA (View Kaletra Review and Kaletra Label ), FERROUS SULFATE (View Ferrous Sulfate Review and Ferrous Sulfate Label ), KETOCONOZOLE (View Ketoconozole Review and Ketoconozole Label ).

6909113-3 | Premature Baby, Small For Dates Baby, Talipes
Adverse event was reported on Jul 27, 2010 by a Male patient taking Viramune (View Usage) (Dosage: ) . Location: , weighting 3.09 lb, Patient experienced the following unwanted or unexpected effects: premature baby, small for dates baby, talipes. During the same period patient was treated with FERROUS SULFATE (View Ferrous Sulfate Review and Ferrous Sulfate Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), LORATADINE (View Loratadine Review and Loratadine Label ), VIRACEPT (View Viracept Review and Viracept Label ), COMBIVIR (View Combivir Review and Combivir Label ).

6909112-1 | Congenital Central Nervous System Anomaly, Umbilical Hernia
on Jul 27, 2010 Male patient from , weighting 5.73 lb, was treated with Viramune (View Usage). Patient had the following side effects: congenital central nervous system anomaly, umbilical hernia. Viramune dosage: . During the same period patient was treated with COMBIVIR (View Combivir Review and Combivir Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), IRON PREPARATIONS (View Iron Preparations Review and Iron Preparations Label ), MEBENDAZOLE (View Mebendazole Review and Mebendazole Label ), NYSTATIN (View Nystatin Review and Nystatin Label ), SECNIDAZOLE (View Secnidazole Review and Secnidazole Label ).

6908462-2 | Patent Ductus Arteriosus, Umbilical Hernia
on Jul 27, 2010 Female patient from , weighting 6.17 lb, was treated with Viramune (View Usage). After Viramune was administered, patient had the following side effects: patent ductus arteriosus, umbilical hernia. Viramune dosage: . During the same period patient was treated with VIRACEPT (View Viracept Review and Viracept Label ), VIDEX (View Videx Review and Videx Label ), COMBIVIR (View Combivir Review and Combivir Label ), ASCORBIC ACID (VIT C) (View Ascorbic Acid (vit C) Review and Ascorbic Acid (vit C) Label ), BENZATHINE BENZYLPE (View Benzathine Benzylpe Review and Benzathine Benzylpe Label ), DEXCHLORPHENIRAMINE MALEATE (View Dexchlorpheniramine Maleate Review and Dexchlorpheniramine Maleate Label ), IRON PREPARATIONS (View Iron Preparations Review and Iron Preparations Label ), NEBACETIN (View Nebacetin Review and Nebacetin Label ).

6908101-0 | Haemangioma
Patient was taking Viramune (View Usage). Patient experienced the following unwanted or unexpected effects: haemangioma on Jul 27, 2010 from Additional patient health information: Female patient , weighting 7.28 lb, . Viramune dosage: . During the same period patient was treated with COMBIVIR (View Combivir Review and Combivir Label ), CEPHALEXIN (View Cephalexin Review and Cephalexin Label ), IRON PREPARATIONS (View Iron Preparations Review and Iron Preparations Label ).

6908099-5 | Congenital Hydronephrosis
Adverse event was reported on Jul 27, 2010 by a Female patient taking Viramune (View Usage) (Dosage: ) . Location: , weighting 4.19 lb, Patient had the following side effects: congenital hydronephrosis. During the same period patient was treated with VIDEX (View Videx Review and Videx Label ), COMBIVIR (View Combivir Review and Combivir Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), IRON PREPARATIONS (View Iron Preparations Review and Iron Preparations Label ).

6907869-7 | Ventricular Septal Defect
on Jul 27, 2010 Female patient from , weighting 5.29 lb, was treated with Viramune (View Usage). After Viramune was administered, patient had the following side effects: ventricular septal defect. Viramune dosage: . During the same period patient was treated with EPIVIR (View Epivir Review and Epivir Label ), VIDEX (View Videx Review and Videx Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), BENZATHINE BENZYLPE (View Benzathine Benzylpe Review and Benzathine Benzylpe Label ), TOBACCO (View Tobacco Review and Tobacco Label ).

6907146-4 | Ventricular Septal Defect
on Jul 27, 2010 Female patient from , weighting 6.61 lb, was treated with Viramune (View Usage). Patient experienced the following unwanted or unexpected effects: ventricular septal defect. Viramune dosage: . During the same period patient was treated with COMBIVIR (View Combivir Review and Combivir Label ), CEPHALEXIN (View Cephalexin Review and Cephalexin Label ), TINIDAZOLE (View Tinidazole Review and Tinidazole Label ), FERROUS SULFATE (View Ferrous Sulfate Review and Ferrous Sulfate Label ).

6906953-1 | Arrhythmia
Patient was taking Viramune (View Usage). Patient had the following side effects: arrhythmia (What is arrhythmia?) on Jul 27, 2010 from Additional patient health information: Female patient , weighting 7.28 lb, . Viramune dosage: . During the same period patient was treated with COMBIVIR (View Combivir Review and Combivir Label ).

6906741-6 | Atrial Septal Defect, Congenital Pulmonary Valve Disorder, Mitral Valve Hypoplasia, Pulmonary Valve Stenosis, Ventricular Hypoplasia
Adverse event was reported on Aug 02, 2010 by a Female patient taking Viramune (View Usage) (Dosage: ) . Location: , weighting 5.51 lb, After Viramune was administered, patient had the following side effects: atrial septal defect, congenital pulmonary valve disorder, mitral valve hypoplasia, pulmonary valve stenosis, ventricular hypoplasia. During the same period patient was treated with VIRACEPT (View Viracept Review and Viracept Label ), COMBIVIR (View Combivir Review and Combivir Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), IRON PREPARATIONS (View Iron Preparations Review and Iron Preparations Label ), MEBENDAZOLE (View Mebendazole Review and Mebendazole Label ), NYSTATIN (View Nystatin Review and Nystatin Label ).

6906284-X | Polydactyly
on Jul 27, 2010 Female patient from , weighting 7.94 lb, was treated with Viramune (View Usage). Patient experienced the following unwanted or unexpected effects: polydactyly. Viramune dosage: . During the same period patient was treated with COMBIVIR (View Combivir Review and Combivir Label ).

6906056-6 | Hydrocele, Inguinal Hernia
on Jul 27, 2010 Male patient from , weighting 9.26 lb, was treated with Viramune (View Usage). Patient had the following side effects: hydrocele, inguinal hernia. Viramune dosage: . During the same period patient was treated with COMBIVIR (View Combivir Review and Combivir Label ), FERROUS SULFATE (View Ferrous Sulfate Review and Ferrous Sulfate Label ).

6901996-6 | Hip Dysplasia
Patient was taking Viramune (View Usage). After Viramune was administered, patient had the following side effects: hip dysplasia on Jul 27, 2010 from Additional patient health information: Female patient , weighting 8.82 lb, . Viramune dosage: . During the same period patient was treated with COMBIVIR (View Combivir Review and Combivir Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), IRON (View Iron Review and Iron Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ).

6896347-X | Ventricular Septal Defect
Adverse event was reported on Jul 27, 2010 by a Male patient taking Viramune (View Usage) (Dosage: ) . Location: , weighting 6.39 lb, Patient experienced the following unwanted or unexpected effects: ventricular septal defect. During the same period patient was treated with COMBIVIR (View Combivir Review and Combivir Label ), BACTRIM (View Bactrim Review and Bactrim Label ), FERROUS SULFATE (View Ferrous Sulfate Review and Ferrous Sulfate Label ).

6888546-8 | Trisomy 21
on Jul 23, 2010 Female patient from , weighting 7.25 lb, was treated with Viramune (View Usage). Patient had the following side effects: trisomy 21. Viramune dosage: . During the same period patient was treated with KALETRA (View Kaletra Review and Kaletra Label ), VIREAD (View Viread Review and Viread Label ).

6888459-1 | Abortion Spontaneous, Placental Disorder, Placental Transfusion Syndrome, Stillbirth
on Jul 21, 2010 Female patient from , 34 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Viramune (View Usage). After Viramune was administered, patient had the following side effects: abortion spontaneous, placental disorder, placental transfusion syndrome, stillbirth. Viramune dosage: 400 Mg. During the same period patient was treated with TRUVADA (245 Mg) (View Truvada Review and Truvada Label ), LAMIVUDINE (300 Mg) (View Lamivudine Review and Lamivudine Label ).

6884107-5 | Abortion Spontaneous
Patient was taking Viramune (View Usage). Patient experienced the following unwanted or unexpected effects: abortion spontaneous on Jul 15, 2010 from Additional patient health information: Female patient , 40 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Viramune dosage: . During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ).

6882486-6 | Abdominal Pain, Muscle Rupture
Adverse event was reported on Jul 26, 2010 by a Female patient taking Viramune (View Usage) (Dosage: 400 Mg) was diagnosed with hiv infection (What is hiv infection?) and. Location: , weighting 161.4 lb, Patient had the following side effects: abdominal pain (What is abdominal pain?), muscle rupture. During the same period patient was treated with TRUVADA (1 Anz) (View Truvada Review and Truvada Label ). Patient was hospitalized.

6880909-X | Foot Deformity
on Jul 19, 2010 Male patient from , weighting 5.29 lb, was treated with Viramune (View Usage). After Viramune was administered, patient had the following side effects: foot deformity. Viramune dosage: . During the same period patient was treated with LOPINAVIR/RITONAVIR (View Lopinavir/ritonavir Review and Lopinavir/ritonavir Label ), TENOFOVIR DISOPROXIL FUMARATE (View Tenofovir Disoproxil Fumarate Review and Tenofovir Disoproxil Fumarate Label ).

6876709-7 | Hepatic Failure, Stevens-johnson Syndrome
on Jul 23, 2010 Female patient from , 57 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Viramune (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic failure, stevens-johnson syndrome. Viramune dosage: 400 Mg. During the same period patient was treated with COMBIVENT (View Combivent Review and Combivent Label ), VIREAD (View Viread Review and Viread Label ). Patient was hospitalized.

6875078-6 | Colon Cancer
Patient was taking Viramune (View Usage). Patient had the following side effects: colon cancer on Jul 16, 2010 from Additional patient health information: Male patient , 69 years of age, weighting 137.8 lb, was diagnosed with hiv infection (What is hiv infection?) and. Viramune dosage: 400 Mg. Patient was hospitalized.